These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11375769)

  • 21. Application of topological descriptors in QSAR and drug design: history and new trends.
    Gozalbes R; Doucet JP; Derouin F
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):93-102. PubMed ID: 12462157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling.
    Dong X; Ebalunode JO; Yang SY; Zheng W
    Curr Comput Aided Drug Des; 2011 Sep; 7(3):181-9. PubMed ID: 21726192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods and applications of structure based pharmacophores in drug discovery.
    Pirhadi S; Shiri F; Ghasemi JB
    Curr Top Med Chem; 2013; 13(9):1036-47. PubMed ID: 23651482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore fingerprinting. 2. Application to primary library design.
    McGregor MJ; Muskal SM
    J Chem Inf Comput Sci; 2000; 40(1):117-25. PubMed ID: 10661558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospect and prospect of virtual screening in drug discovery.
    Xu H
    Curr Top Med Chem; 2002 Dec; 2(12):1305-20. PubMed ID: 12470282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore.
    Siani MA; Skillman AG; Carreras CW; Ashley G; Kuntz ID; Santi DV
    J Mol Graph Model; 2000; 18(4-5):497-511, 539-40. PubMed ID: 11143565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances on the role of topological indices in drug discovery research.
    Estrada E; Uriarte E
    Curr Med Chem; 2001 Nov; 8(13):1573-88. PubMed ID: 11562286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.
    Tropsha A; Zheng W
    Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtual screening: an effective tool for lead structure discovery?
    Langer T; Hoffmann RD
    Curr Pharm Des; 2001 May; 7(7):509-27. PubMed ID: 11375766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular fingerprinting on the SIMD parallel processor Kestrel.
    Rice E; Hughey R
    Pac Symp Biocomput; 2001; ():323-34. PubMed ID: 11262952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application.
    Baroni M; Cruciani G; Sciabola S; Perruccio F; Mason JS
    J Chem Inf Model; 2007; 47(2):279-94. PubMed ID: 17381166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.
    Wolber G; Langer T
    J Chem Inf Model; 2005; 45(1):160-9. PubMed ID: 15667141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors.
    Matter H
    J Med Chem; 1997 Apr; 40(8):1219-29. PubMed ID: 9111296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of random sampling to virtual screening of combinatorial libraries.
    Beroza P; Bradley EK; Eksterowicz JE; Feinstein R; Greene J; Grootenhuis PD; Henne RM; Mount J; Shirley WA; Smellie A; Stanton RV; Spellmeyer DC
    J Mol Graph Model; 2000; 18(4-5):335-42. PubMed ID: 11143553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.